iShares Nasdaq Biotechnology ETF (IBB) Stake Boosted by HPM Partners LLC

HPM Partners LLC grew its position in iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) by 4.1% during the second quarter, HoldingsChannel.com reports. The firm owned 23,074 shares of the financial services provider’s stock after buying an additional 900 shares during the quarter. HPM Partners LLC’s holdings in iShares Nasdaq Biotechnology ETF were worth $2,534,000 as of its most recent filing with the Securities & Exchange Commission.

Several other large investors have also recently added to or reduced their stakes in IBB. Natixis increased its position in iShares Nasdaq Biotechnology ETF by 8.7% during the second quarter. Natixis now owns 1,250,000 shares of the financial services provider’s stock worth $137,275,000 after acquiring an additional 100,000 shares during the period. Royal Bank of Canada increased its position in iShares Nasdaq Biotechnology ETF by 3.6% during the first quarter. Royal Bank of Canada now owns 898,480 shares of the financial services provider’s stock worth $95,902,000 after acquiring an additional 30,947 shares during the period. PNC Financial Services Group Inc. increased its position in iShares Nasdaq Biotechnology ETF by 0.4% during the second quarter. PNC Financial Services Group Inc. now owns 639,136 shares of the financial services provider’s stock worth $70,190,000 after acquiring an additional 2,256 shares during the period. Commerzbank Aktiengesellschaft FI increased its position in iShares Nasdaq Biotechnology ETF by 54.0% during the second quarter. Commerzbank Aktiengesellschaft FI now owns 585,506 shares of the financial services provider’s stock worth $64,300,000 after acquiring an additional 205,200 shares during the period. Finally, LPL Financial LLC increased its position in iShares Nasdaq Biotechnology ETF by 11.9% during the first quarter. LPL Financial LLC now owns 512,225 shares of the financial services provider’s stock worth $54,675,000 after acquiring an additional 54,371 shares during the period. 64.16% of the stock is currently owned by institutional investors.

Shares of iShares Nasdaq Biotechnology ETF stock opened at $117.77 on Friday. iShares Nasdaq Biotechnology ETF has a 52-week low of $100.22 and a 52-week high of $122.53.

iShares Nasdaq Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.

Read More: What does relative strength index mean?

Want to see what other hedge funds are holding IBB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for iShares Nasdaq Biotechnology ETF (NASDAQ:IBB).

Institutional Ownership by Quarter for iShares Nasdaq Biotechnology ETF (NASDAQ:IBB)

Receive News & Ratings for iShares Nasdaq Biotechnology ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Nasdaq Biotechnology ETF and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply